Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • hollystephens723
    Member
    • Dec 2018
    • 36

    #1

    precisionFDA aBrain Cancer Predictive Modeling Challenge Extension and New Incentive

    For those who are either currently participating or interested in starting the precisionFDA and Georgetown ICBI Brain Cancer Predictive Modeling and Biomarker Discovery Challenge we have some exciting news! We have extended the challenge submission period, and a new incentive has been offered for the top three submissions! The extension details are as follows:

    • Phase 1 submission period closes on February 5th
    • Phase 2 data will be released February 7th
    • Challenge submission period closes on February 14th

    In addition to the challenge extension, we’ve added an incentive for the top three performing teams. These teams or individuals will be awarded a podium presentation at the 9th Annual Health Informatics and Data Science Symposium[/URL]. This conference is a great opportunity to meet and network with thought leaders in the fields of precision and molecular medicine, health data analytics, and bioinformatics.

    To learn more about the challenge and participate visit https://go.usa.gov/xdbvW. Participants who have already submitted a Phase 1 model may use this additional time to improve upon their model and resubmit.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...